Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revance Therapeutics
(NQ:
RVNC
)
6.570
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revance Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
REVANCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Revance Therapeutics, Inc. - RVNC
August 15, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, RVNC, BALY, DRQ on Behalf of Shareholders
August 13, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Gold Gains Over 1%; Starbucks Shares Move Higher
August 12, 2024
Via
Benzinga
Why Is Revance Therapeutics (RVNC) Stock Up 86% Today?
August 12, 2024
Revance Therapeutics stock is up on Monday as RVNC investors celebrate a $924 million merger agreement with Crown Laboratories.
Via
InvestorPlace
Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal
August 12, 2024
Crown Laboratories will acquire Revance Therapeutics for $924 million, paying $6.66 per share — a premium of 89%.
Via
Benzinga
Crude Oil Surges 2%; B. Riley Financial Shares Plunge
August 12, 2024
Via
Benzinga
Exposures
Fossil Fuels
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Revance Therapeutics, Inc. (Nasdaq – RVNC), Greenbrook TMS, Inc. (OTC – GBNHF), R1 RCM Inc. (Nasdaq - RCM), Enstar Group Limited (Nasdaq – ESGR)
August 12, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
KE Holdings, KeyCorp, Revance Therapeutics, Starbucks And Other Big Stocks Moving Higher On Monday
August 12, 2024
Via
Benzinga
RVNC Investigation: Halper Sadeh LLC Is Investigating Whether the Sale of Revance Therapeutics, Inc. Is Fair to Shareholders
August 12, 2024
From
Halper Sadeh LLC
Via
Business Wire
Dow Dips 150 Points; Monday.com Posts Upbeat Earnings
August 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
RVNC Stock Earnings: Revance Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
RVNC stock results show that Revance Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update
August 08, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
August 01, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
July 22, 2024
The big pharma company's top drug is losing ground, but its dividend keeps rising.
Via
The Motley Fool
Stocks to Buy: 3 Breakout Stars to Transform Your Portfolio
July 11, 2024
Although breakout stocks present high risks, the underlying lack of predictability provides fuel for tremendous upside.
Via
InvestorPlace
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 14, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance to Participate in Upcoming Investor Conferences
May 28, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
May 22, 2024
Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them.
Via
InvestorPlace
3 Underappreciated Stocks That Could 10x in 10 Years
May 12, 2024
10x stocks are the holy grail of capital investing. So, here are three companies that have the potential to cross that line.
Via
InvestorPlace
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
These Analysts Lower Their Forecasts On Revance Therapeutics After Q1 Results
May 10, 2024
Via
Benzinga
RVNC Stock Earnings: Revance Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
RVNC stock results show that Revance Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
May 09, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia
May 09, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 02, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
April 12, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
April 09, 2024
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 27, 2024
From
Revance Therapeutics, Inc.
Via
Business Wire
GDS Holdings, Coinbase And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 11, 2024
U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdings Limited (NASDAQ: GDS) shares rose sharply in today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.